# SABSW (Sab Biotherapeutics, Inc.) - SEC EDGAR Financial Statements

> Sab Biotherapeutics, Inc. reported $0 in revenue and a net loss of $80.52M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/SABSW
- Markdown: https://convexityos.com/fundamentals/SABSW.md
- SEC CIK: 0001833214
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:41 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001833214&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | -100.0% YoY |
| Operating Income | FY 2025 | -$85.04M | Operating profit |
| Net Income | FY 2025 | -$80.52M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.86 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$45.71M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $104.0M | Total debt: $4.92M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $1.32M | $2.24M | $23.90M | $60.88M | $55.24M |
| Research & Development | $34.35M | $30.25M | $16.52M | $36.44M | $57.18M | $27.91M |
| Total Operating Expenses | $48.95M | $44.23M | $40.31M | $52.82M | $74.27M | $34.68M |
| **Operating Income** | -$48.95M | -$42.91M | -$38.08M | -$28.92M | -$13.39M | $20.56M |
| **EBITDA** | -$45.96M | -$38.20M | -$34.42M | -$25.75M | -$11.90M | $20.94M |
| Interest Income | $1.43M | $1.29M | $585K | $71K | $23K | $26K |
| Interest Expense | $241K | $318K | $315K | $302K | $294K | $469K |
| Income Before Tax | $13.27M | -- | -$42.19M | -$18.72M | -$17.14M | $20.12M |
| Income Tax Expense | $0 | $0 | $0 | $26K | $0 | $0 |
| **Net Income** | $13.27M | -$34.11M | -$42.19M | -$18.74M | -$17.14M | $20.12M |
| Basic EPS | $0.22 | -$3.68 | -$7.64 | -$4.31 | -$6.30 | $7.90 |
| **Diluted EPS** | -$0.79 | -$3.68 | -$7.64 | -$4.31 | -$6.30 | $7.40 |
| Basic Shares Outstanding | 19.3M | 9.3M | 5.5M | 4.4M | 2.7M | 2.5M |
| Diluted Shares Outstanding | 61.3M | 9.3M | 5.5M | 4.4M | 2.7M | 2.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | -- | $115K |
| Research & Development | $18.08M | $16.17M | $13.40M | $10.73M | $8.97M | $7.00M | $7.66M | $7.65M |
| Total Operating Expenses | $25.90M | $23.38M | $20.00M | $15.77M | $12.68M | $9.73M | $10.77M | $10.12M |
| **Operating Income** | -$25.90M | -$23.38M | -$20.00M | -$15.77M | -$12.68M | -$9.73M | -$10.77M | -$10.01M |
| **EBITDA** | -$25.10M | -$22.58M | -$19.27M | -$15.03M | -$11.98M | -$8.93M | -$10.02M | -$9.24M |
| Interest Income | -- | $1.71M | $1.05M | $701K | $655K | $14K | $62K | $136K |
| Interest Expense | -- | $62K | $63K | $63K | $43K | $64K | $70K | $71K |
| **Net Income** | -$22.30M | -$22.49M | -$18.87M | -$16.86M | $45.45M | -$10.11M | -$5.20M | -$11.39M |
| Basic EPS | -$0.24 | -$0.28 | -$0.35 | -- | $0.50 | -$1.09 | -$0.56 | -- |
| **Diluted EPS** | -$0.24 | -$0.28 | -$0.35 | -- | -$0.21 | -$1.09 | -$0.56 | -- |
| Basic Shares Outstanding | 93.2M | 79.8M | 53.6M | -- | 10.7M | 9.3M | 9.3M | -- |
| Diluted Shares Outstanding | 93.2M | 79.8M | 53.6M | -- | 77.9M | 9.3M | 9.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $10.50M | $8.90M | $56.57M | $15.05M | $16.62M | $22.41M | $33.21M | $12.61M |
| Short-Term Investments | $86.09M | $11.86M | $0 | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $96.59M | $20.76M | $56.57M | $15.05M | $16.62M | $22.41M | $39.55M | $12.61M |
| Accounts Receivable, Net | -- | -- | $0 | $5.56M | $9.61M | $11.79M | $8.01M | $20.57M |
| **Total Current Assets** | $101.1M | $23.79M | $58.91M | $22.10M | $28.00M | $37.18M | $50.19M | $34.46M |
| Property, Plant & Equipment, Net | $13.31M | $15.37M | $19.74M | $23.25M | $24.84M | $24.97M | $24.31M | $14.85M |
| Long-Term Investments | $46.89M | -- | $0 | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $71.76M | $20.40M | $25.03M | $28.81M | $31.40M | $31.30M | $30.95M | $22.08M |
| **Total Assets** | $172.8M | $44.20M | $83.94M | $50.90M | $59.41M | $68.49M | $81.14M | $56.54M |
| Accounts Payable | $3.15M | $1.69M | $946K | $3.68M | $4.94M | $4.98M | $4.46M | $7.38M |
| **Total Current Liabilities** | $10.68M | $7.98M | $10.81M | $14.99M | $16.39M | $19.27M | $26.46M | $11.06M |
| **Total Non-Current Liabilities** | $10.63M | $10.25M | $15.83M | $4.85M | $5.90M | $7.96M | $16.14M | $6.47M |
| **Total Liabilities** | $21.32M | $18.23M | $26.64M | $19.85M | $22.29M | $27.23M | $42.59M | $17.53M |
| **Total Debt (incl. Leases)** | $5.95M | $4.39M | $4.86M | $4.61M | $6.07M | $6.39M | $6.72M | $7.42M |
| Common Stock | $5.0K | $935 | $929 | $510 | $4.4K | $4.3K | $4.3K | $2.6K |
| Retained Earnings | -$110.9M | -$124.2M | -$90.06M | -$47.87M | -$32.92M | -$28.14M | -$29.13M | -$11.98M |
| Accumulated Other Comp. Income | $187K | -$135K | $26K | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $151.5M | $25.97M | $57.30M | $31.06M | $37.12M | $41.26M | $38.55M | $39.01M |
| Total Equity | $151.5M | $25.97M | $57.30M | $31.06M | $37.12M | $41.26M | $38.55M | $39.01M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $14.44M | $8.27M | $20.52M | $10.50M | $29.42M | $3.69M | $5.64M | $8.90M |
| Short-Term Investments | $89.61M | $94.36M | $86.87M | $86.09M | $81.46M | $2.02M | $7.21M | $11.86M |
| **Cash & Short-Term Investments** | $104.0M | $102.6M | $107.4M | $96.59M | $110.9M | $5.71M | $12.85M | $20.76M |
| **Total Current Assets** | $107.7M | $107.9M | $112.8M | $101.1M | $113.3M | $9.31M | $16.30M | $23.79M |
| Property, Plant & Equipment, Net | $15.65M | $14.23M | $13.81M | $13.31M | $13.11M | $13.86M | $14.61M | $15.37M |
| Long-Term Investments | $101.3M | $105.3M | $110.2M | $46.89M | $50.61M | -- | -- | -- |
| **Total Non-Current Assets** | $127.9M | $130.3M | $135.7M | $71.76M | $70.17M | $20.82M | $21.82M | $20.40M |
| **Total Assets** | $235.6M | $238.2M | $248.5M | $172.8M | $183.4M | $30.13M | $38.12M | $44.20M |
| Accounts Payable | $2.42M | $3.85M | $3.54M | $3.15M | $2.95M | $2.62M | $2.52M | $1.69M |
| **Total Current Liabilities** | $14.80M | $11.71M | $9.85M | $10.68M | $10.79M | $10.68M | $9.65M | $7.98M |
| **Total Non-Current Liabilities** | $9.93M | $11.72M | $11.37M | $10.63M | $7.58M | $7.44M | $7.06M | $10.25M |
| **Total Liabilities** | $24.72M | $23.43M | $21.22M | $21.32M | $18.37M | $18.11M | $16.71M | $18.23M |
| **Total Debt (incl. Leases)** | $4.92M | $5.13M | $6.17M | $5.95M | $6.19M | $6.42M | $6.64M | $4.39M |
| Common Stock | $9.0K | $8.0K | $7.6K | $5.0K | $4.8K | $936 | $936 | $935 |
| Retained Earnings | -$174.6M | -$152.3M | -$129.8M | -$110.9M | -$94.03M | -$139.5M | -$129.4M | -$124.2M |
| Accumulated Other Comp. Income | -$2.30M | -$930K | -$223K | $187K | $71K | -$16K | -$112K | -$135K |
| **Total Stockholders' Equity** | $210.9M | $214.8M | $227.2M | $151.5M | $165.1M | $12.02M | $21.41M | $25.97M |
| Total Equity | $210.9M | $214.8M | $227.2M | $151.5M | $165.1M | $12.02M | $21.41M | $25.97M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | $13.27M | -$34.11M | -$42.19M | -$18.74M | -$17.14M | $20.12M |
| Depreciation & Amortization | $2.99M | $4.71M | $3.65M | $3.17M | $1.49M | $383K |
| Stock-Based Compensation | $5.21M | $2.94M | $2.42M | $2.67M | $2.31M | $1.30M |
| Change in Receivables | -- | -- | $5.56M | $2.45M | $12.56M | -$17.75M |
| Change in Payables | $1.48M | $923K | -$2.70M | -$779K | -$2.94M | $5.21M |
| **Operating Cash Flow** | -$44.78M | -$34.29M | -$25.12M | -$23.46M | $1.99M | $10.00M |
| Capital Expenditure | -$933K | -$337K | -$197K | -$2.17M | -$10.94M | -$12.73M |
| **Free Cash Flow** | -$45.71M | -$34.63M | -$25.32M | -$25.63M | -$8.96M | -$2.73M |
| Purchases of Investments | -$142.0M | -$37.45M | -- | -- | -- | -- |
| **Investing Cash Flow** | -$121.7M | -$11.96M | -$153K | -$2.09M | -$10.94M | -$12.72M |
| Common Stock Issued | -- | -- | -- | $7.68M | $0 | $9.90M |
| **Financing Cash Flow** | $168.3M | -$1.17M | $66.77M | $1.05M | $35.89M | $8.98M |
| **Net Change in Cash** | $1.60M | -$47.67M | $41.52M | -$24.50M | $26.93M | $6.26M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$22.30M | -$22.49M | -$18.87M | -$16.86M | $45.45M | -$10.11M | -$5.20M | -$11.39M |
| Depreciation & Amortization | $800K | $800K | $731K | $742K | $700K | $800K | $757K | $764K |
| Stock-Based Compensation | $7.44M | $7.25M | $5.46M | $3.17M | $801K | $627K | $613K | $674K |
| Change in Payables | -$2.21M | $675K | $114K | $325K | $336K | $138K | $684K | $590K |
| **Operating Cash Flow** | -$13.02M | -$9.84M | -$14.27M | -$16.78M | -$13.05M | -$7.15M | -$7.80M | -$9.53M |
| Capital Expenditure | -$1.34M | -$1.59M | -$983K | -- | -- | -- | -- | -$55K |
| **Free Cash Flow** | -$14.37M | -$11.43M | -$15.25M | -- | -- | -- | -- | -$9.59M |
| Purchases of Investments | -$7.31M | -$13.01M | -$139.3M | -$12.04M | -$129.9M | -$52K | -$71K | -$1.31M |
| **Investing Cash Flow** | $6.07M | -$4.88M | -$65.65M | -$1.71M | -$129.9M | $5.20M | $4.67M | $9.33M |
| **Financing Cash Flow** | $13.00M | $2.36M | $89.92M | -$42K | $168.7M | -$174K | -$174K | $217K |
| **Net Change in Cash** | $6.17M | -$12.25M | $10.02M | -$18.92M | $25.73M | -$1.95M | -$3.26M | -$273K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -3244.9% | -1700.6% | -121.0% | -22.0% | 37.2% |
| **Net Profit Margin** | -- | -2579.0% | -1884.5% | -78.4% | -28.2% | 36.4% |
| Return on Equity (ROE) | 8.8% | -131.3% | -73.6% | -60.3% | -44.5% | 51.6% |
| Return on Assets (ROA) | 7.7% | -77.2% | -50.3% | -36.8% | -21.1% | 35.6% |
| Current Ratio | 9.46x | 2.98x | 5.45x | 1.47x | 1.90x | 3.11x |
| Quick Ratio | 9.04x | 2.60x | 5.23x | 1.37x | 1.80x | 3.00x |
| Debt to Equity | 0.04x | 0.17x | 0.08x | 0.15x | 0.17x | 0.19x |
| **Revenue Growth (YoY)** | -100.0% | -40.9% | -90.6% | -60.7% | +10.2% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -165.2% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -185.2% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -179.7% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -1280.7% | -80.1% | -- |
| 5Y Revenue / Share Growth | -100.0% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -91.3% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -3244.9% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -2579.0% |
| Return on Equity (ROE) | -38.2% | -5.9% | -0.2% | 8.8% | 11.4% | -308.4% | -160.1% | -131.3% |
| Return on Assets (ROA) | -34.2% | -5.4% | -0.2% | 7.7% | 10.2% | -123.0% | -89.9% | -77.2% |
| Current Ratio | 7.28x | 9.22x | 11.45x | 9.46x | 10.50x | 0.87x | 1.69x | 2.98x |
| Quick Ratio | 7.03x | 8.77x | 10.90x | 9.04x | 10.27x | 0.54x | 1.33x | 2.60x |
| Debt to Equity | 0.02x | 0.02x | 0.03x | 0.04x | 0.04x | 0.53x | 0.31x | 0.17x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -62.4% |
| **Net Income Growth (YoY)** | -149.1% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -148.0% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
